Emirates Drug Establishment showcases InSilico project and signs MoU to advance pharmaceutical innovation
Emirates Drug Establishment signs cooperation agreement with Emirates Medical Association at WHX 2026
Emirates Drug Establishment strengthens international partnerships and showcases ‘Organ on Chip’ project at World Health Expo 2026
Saeed bin Mubarak Al Hajeri holds bilateral meetings with international strategic partners
Emirates Drug Establishment, Mubadala Bio Limited sign MoU to develop pharmaceutical manufacturing
Saeed bin Mubarak Al Hajeri launches Emirates Drug Establishment at World Health Expo 2026
Emirates Drug Establishment to launch officially and unveil national pharmaceutical initiatives at WHX 2026
UAE becomes second nation worldwide to grant approval
Move is part of EDE’s commitment to maintaining the highest standards of quality and safety
H.E. Saeed Al Hajri: "The Emirates Drug Establishment plays a fundamental role in solidifying the country’s leadership and sustainability in the pharmaceutical sector."
UAE becomes world's second country to approve "Itvisma" following US FDA.
H.E. Dr. Fatima Al Kaabi: EDE is committed to establishing a regulatory environment that supports innovation, ensures patient safety, and enhances clinical research
